Search research articles
Contact Us
Filters
Showing results (21-30 of 23) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 23 results.
Medicine
|
December 8, 2020
A randomized, multi-center, open-label study to compare the safety and efficacy between afatinib monotherapy and combination therapy of afatinib and HAD-B1 for the locally advanced or metastatic NSCLC patients with EGFR mutations
Si-Yeon Song, Su-Jeong Ha, Ji-Hye Park, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials
|
August 9, 2019
Fabrication and biological activity of polycaprolactone/phlorotannin endotracheal tube to prevent tracheal stenosis: An in vitro and in vivo study
Hyoung Shin Lee, Min-Seon Jeong, Seok-Chun Ko, et al.
Integrative Cancer Therapies
|
August 5, 2024
A Randomized, Multi-Center, Open Label Study to Compare the Safety and Efficacy between Afatinib Monotherapy and Combination Therapy with HAD-B1 for the Locally Advanced or Metastatic NSCLC Patients with EGFR Mutations
Eunbin Kwag, Soo-Dam Kim, Seong-Hoon Shin, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 23) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 23 results.
Medicine
|
December 8, 2020
A randomized, multi-center, open-label study to compare the safety and efficacy between afatinib monotherapy and combination therapy of afatinib and HAD-B1 for the locally advanced or metastatic NSCLC patients with EGFR mutations
Si-Yeon Song, Su-Jeong Ha, Ji-Hye Park, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials
|
August 9, 2019
Fabrication and biological activity of polycaprolactone/phlorotannin endotracheal tube to prevent tracheal stenosis: An in vitro and in vivo study
Hyoung Shin Lee, Min-Seon Jeong, Seok-Chun Ko, et al.
Integrative Cancer Therapies
|
August 5, 2024
A Randomized, Multi-Center, Open Label Study to Compare the Safety and Efficacy between Afatinib Monotherapy and Combination Therapy with HAD-B1 for the Locally Advanced or Metastatic NSCLC Patients with EGFR Mutations
Eunbin Kwag, Soo-Dam Kim, Seong-Hoon Shin, et al.
Page
of 3